|
BE616646A
(https=)
|
|
|
|
|
|
DE1124485B
(de)
|
1960-02-12 |
1962-03-01 |
Hoechst Ag |
Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
|
|
JPS6033106B2
(ja)
|
1977-10-07 |
1985-08-01 |
住友化学工業株式会社 |
カルボン酸エステル、その製造法およびそれを有効成分とする殺虫、殺ダニ剤
|
|
ZA817261B
(en)
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
|
US4540690A
(en)
|
1982-02-09 |
1985-09-10 |
The Upjohn Company |
2-(Phenylmethylene)cycloalkylamines and -azetidines
|
|
JPS58177915A
(ja)
|
1982-04-12 |
1983-10-18 |
Green Cross Corp:The |
抗血栓剤
|
|
JPS61502818A
(ja)
|
1984-07-30 |
1986-12-04 |
シェリング・コ−ポレ−ション |
シス、エンド−オクタヒドロシクロペンタ〔ｂ〕ピロ−ル−２−カルボキシレ−トの新規製造方法
|
|
DE3431541A1
(de)
|
1984-08-28 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
|
|
US4738709A
(en)
|
1985-01-10 |
1988-04-19 |
Ppg Industries, Inc. |
Herbicidally active substituted benzisoxazoles
|
|
US4751231A
(en)
|
1987-09-16 |
1988-06-14 |
Merck & Co., Inc. |
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
|
|
JPH01172388A
(ja)
|
1987-12-25 |
1989-07-07 |
Sumitomo Chem Co Ltd |
チエノ〔３，２−ｂ〕ピロロ〔２，３−ｄ〕ピロール類およびその製法
|
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
|
US4960786A
(en)
|
1989-04-24 |
1990-10-02 |
Merrell Dow Pharmaceuticals Inc. |
Excitatory amino acid antagonists
|
|
JPH0347123A
(ja)
|
1989-05-05 |
1991-02-28 |
G D Searle & Co |
インドール―２―カルボキシレート化合物類を含有するｃｎｓ疾患治療用組成物
|
|
US5137910A
(en)
|
1989-05-05 |
1992-08-11 |
C.D. Searle & Co. |
Compositions containing indole-2-carboxylate compounds for treatment of CNS disorders
|
|
KR100195656B1
(ko)
|
1989-05-31 |
1999-06-15 |
로버트 에이.아미테이지 |
치료학적으로 유용한 2-아미노테트랄린 유도체
|
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
|
US5284862A
(en)
|
1991-03-18 |
1994-02-08 |
Warner-Lambert Company |
Derivatives of 2-carboxyindoles having pharmaceutical activity
|
|
GB9208492D0
(en)
|
1992-04-16 |
1992-06-03 |
Glaxo Spa |
Heterocyclic compounds
|
|
WO1993022299A1
(en)
*
|
1992-04-24 |
1993-11-11 |
E.I. Du Pont De Nemours And Company |
Fungicidal oxazolidinones
|
|
CA2146755A1
(en)
|
1992-10-28 |
1994-05-11 |
Kenji Takeda |
Novel 1,2-benzoisoxazole derivative or its salt and brain-protecting agent comprising the same
|
|
GB9304500D0
(en)
|
1993-03-05 |
1993-04-21 |
Glaxo Spa |
Heterocyclic compounds
|
|
ES2081747B1
(es)
|
1993-09-07 |
1997-01-16 |
Esteve Labor Dr |
Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
|
|
GB9321221D0
(en)
|
1993-10-14 |
1993-12-01 |
Glaxo Spa |
Heterocyclic compounds
|
|
CN1047384C
(zh)
|
1994-07-28 |
1999-12-15 |
北京大学 |
雷米普利的合成方法
|
|
ES2208690T3
(es)
|
1994-08-30 |
2004-06-16 |
Sankyo Company Limited |
Isoxazol.
|
|
US5484763A
(en)
|
1995-02-10 |
1996-01-16 |
American Cyanamid Company |
Substituted benzisoxazole and benzisothiazole herbicidal agents
|
|
GB9502695D0
(en)
|
1995-02-11 |
1995-03-29 |
Glaxo Spa |
Pharmaceutical composition
|
|
CA2217707A1
(en)
|
1995-04-10 |
1996-10-17 |
Fujisawa Pharmaceutial Co., Ltd. |
Indole derivatives as cgmp-pde inhibitors
|
|
US5620997A
(en)
|
1995-05-31 |
1997-04-15 |
Warner-Lambert Company |
Isothiazolones
|
|
US5859042A
(en)
*
|
1995-09-27 |
1999-01-12 |
Ono Pharmaceutical Co., Ltd. |
Five membered heterocyclic compounds
|
|
AU7073296A
(en)
*
|
1996-05-01 |
1997-11-19 |
Eli Lilly And Company |
5,6,7,8-tetrahydropyrido{2,3-d}pyrimidines
|
|
FR2753098B1
(fr)
|
1996-09-06 |
1998-11-27 |
Sod Conseils Rech Applic |
Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
|
|
US5922752A
(en)
|
1997-06-11 |
1999-07-13 |
Hoechst Marion Roussell, Inc. |
NMDA (n-methyl-d-aspartate) antagonists
|
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
|
FR2789079B3
(fr)
*
|
1999-02-01 |
2001-03-02 |
Sanofi Synthelabo |
Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant
|
|
US6828460B2
(en)
|
1999-03-22 |
2004-12-07 |
Pfizer Inc. |
Resorcinol derivatives
|
|
FR2795733B1
(fr)
|
1999-06-30 |
2001-09-07 |
Aventis Pharma Sa |
Derives de streptogramines, leur preparation et les compositions qui les contiennent
|
|
AU6462500A
(en)
|
1999-07-29 |
2001-02-19 |
Patrick T. Prendergast |
Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
|
|
ATE257480T1
(de)
|
1999-09-30 |
2004-01-15 |
Pfizer Prod Inc |
Bicyclische pyrrolylamide als glycogenphosphorylase-inhibitoren
|
|
EP1391460A1
(en)
|
1999-09-30 |
2004-02-25 |
Pfizer Products Inc. |
Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
|
HU230030B1
(hu)
|
1999-10-08 |
2015-05-28 |
Debiopharm International Sa |
Fab I inhibitorok
|
|
US6528254B1
(en)
|
1999-10-29 |
2003-03-04 |
Stratagene |
Methods for detection of a target nucleic acid sequence
|
|
SE9903998D0
(sv)
|
1999-11-03 |
1999-11-03 |
Astra Ab |
New compounds
|
|
JP2001247462A
(ja)
|
2000-03-07 |
2001-09-11 |
Otsuka Pharmaceut Co Ltd |
ウレアーゼ阻害剤
|
|
US6632417B2
(en)
|
2000-03-07 |
2003-10-14 |
Chevron U.S.A. Inc. |
Process for preparing zeolites
|
|
EP1136071A3
(en)
|
2000-03-22 |
2003-03-26 |
Pfizer Products Inc. |
Use of glycogen phosphorylase inhibitors
|
|
US6632948B2
(en)
|
2000-04-19 |
2003-10-14 |
Kaneka Corporation |
Azetidine derivative and process for preparation thereof
|
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
WO2002012249A2
(en)
|
2000-08-04 |
2002-02-14 |
Eli Lilly And Company |
Substituted pyrrole compounds and their use as spla2 inhibitors
|
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2002031128A1
(en)
|
2000-10-06 |
2002-04-18 |
Smithkline Beecham Corporation |
Methods of agonizing and antagonizing fabk
|
|
TWI283575B
(en)
|
2000-10-31 |
2007-07-11 |
Eisai Co Ltd |
Medicinal compositions for concomitant use as anticancer agent
|
|
DE10063992A1
(de)
|
2000-12-21 |
2002-07-04 |
Max Planck Gesellschaft |
Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen
|
|
US6372919B1
(en)
|
2001-01-11 |
2002-04-16 |
Dov Pharmaceutical, Inc. |
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
|
|
EP1412515A2
(en)
|
2001-01-16 |
2004-04-28 |
Genset |
Treatment of cns disorders using d-amino acid oxidase and d-aspartate oxidase antagonists
|
|
US20020123490A1
(en)
|
2001-03-01 |
2002-09-05 |
Pfizer Inc. |
Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
|
|
WO2003000657A1
(en)
|
2001-06-20 |
2003-01-03 |
Daiichi Pharmaceutical Co., Ltd. |
Diamine derivatives
|
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
|
AU2002328596B2
(en)
|
2001-08-09 |
2007-09-20 |
Daiichi Pharmaceutical Co., Ltd. |
Diamine derivatives
|
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
|
US20030162825A1
(en)
|
2001-11-09 |
2003-08-28 |
Sepracor Inc. |
D-amino acid oxidase inhibitors for learning and memory
|
|
WO2003048113A1
(en)
|
2001-11-30 |
2003-06-12 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
|
GB0205170D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
WO2003091213A1
(en)
|
2002-04-25 |
2003-11-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel amide derivatives or salts thereof
|
|
CA2484582A1
(en)
|
2002-05-03 |
2003-11-13 |
Warner-Lambert Company Llc |
Bombesin antagonists
|
|
JP4459051B2
(ja)
|
2002-07-31 |
2010-04-28 |
メルシャン株式会社 |
新規生理活性物質
|
|
EP1543011B1
(en)
|
2002-09-06 |
2006-05-03 |
Janssen Pharmaceutica N.V. |
Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
|
|
WO2004024130A2
(en)
|
2002-09-16 |
2004-03-25 |
Sepracor, Inc. |
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPTHALENAMINE
|
|
JP4610336B2
(ja)
|
2002-09-16 |
2011-01-12 |
セプラコール インク． |
トランス４−（３，４−ジクロロフェニル）−１，２，３，４−テトラヒドロ−１−ナフタレンアミン及びそのホルムアミドによる中枢神経系障害の治療
|
|
EP1558231A4
(en)
|
2002-10-03 |
2010-09-08 |
Cypress Bioscience Inc |
DOSAGE CLIMBING AND FRICTIONAL DAILY DOSE OF ANTIDEPRESSANTS TO TREAT NEUROLOGICAL DISORDERS
|
|
GB0222912D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
|
GB0222909D0
(en)
|
2002-10-03 |
2002-11-13 |
Astrazeneca Ab |
Novel process and intermediates
|
|
US20040097554A1
(en)
|
2002-10-30 |
2004-05-20 |
Pfizer Inc |
Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
|
|
CA2503727A1
(en)
|
2002-11-07 |
2004-05-21 |
Pfizer Products Inc. |
Anti-diabetic agents
|
|
JP4184378B2
(ja)
|
2003-01-31 |
2008-11-19 |
株式会社三和化学研究所 |
ジペプチジルペプチダーゼｉｖを阻害する化合物
|
|
ATE482747T1
(de)
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
|
WO2004096768A1
(en)
|
2003-04-30 |
2004-11-11 |
Pfizer Products Inc. |
Anti-diabetic agents
|
|
WO2004113345A1
(ja)
|
2003-06-20 |
2004-12-29 |
Japan Tobacco Inc. |
縮合ピロール化合物及びその医薬用途
|
|
SI1362864T1
(sl)
|
2003-06-30 |
2007-08-31 |
Servier Lab |
Nov postopek za sintezo perindoprila in njegovih farmacevtsko sprejemljivih soli
|
|
AU2004255863A1
(en)
|
2003-07-07 |
2005-01-20 |
Ciba Specialty Chemicals Holding Inc. |
Process for the preparation of furopyrroles
|
|
AU2004289174B2
(en)
|
2003-07-29 |
2011-05-19 |
Signature R&D Holdings, Lcc |
Amino acid prodrugs
|
|
US20050065183A1
(en)
|
2003-07-31 |
2005-03-24 |
Indranil Nandi |
Fexofenadine composition and process for preparing
|
|
WO2005020986A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
|
|
GB0320422D0
(en)
|
2003-08-30 |
2003-10-01 |
Astrazeneca Ab |
Chemical compounds
|
|
US7396940B2
(en)
|
2003-10-23 |
2008-07-08 |
Hoffmann-La Roche Inc. |
Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
|
|
DE60311942T2
(de)
|
2003-11-19 |
2007-12-06 |
Les Laboratoires Servier |
Verfahren für die Synthese von Perindopril und seiner pharmazeutischen annehmbaren Salzen
|
|
CN101798291A
(zh)
|
2003-12-29 |
2010-08-11 |
塞普拉科公司 |
苯并[d]异噁唑-3-醇DAAO抑制剂
|
|
AU2004312530A1
(en)
|
2003-12-29 |
2005-07-21 |
Sepracor Inc. |
Pyrrole and pyrazole DAAO inhibitors
|
|
CA2559105A1
(en)
|
2004-03-16 |
2005-09-29 |
Janssen Pharmaceutica N.V. |
Benzisoxazoles
|
|
ES2346665T3
(es)
|
2004-05-07 |
2010-10-19 |
Warner-Lambert Company Llc |
Derivados de fenol y tiofenol 3- o 4-monosustituidos utiles como ligandos de h3.
|
|
WO2006001958A2
(en)
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
|
RU2361872C2
(ru)
|
2004-05-26 |
2009-07-20 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Циннамидное соединение
|
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
|
WO2006004040A1
(ja)
|
2004-07-01 |
2006-01-12 |
Daiichi Asubio Pharma Co., Ltd. |
Ｐｄｅ７阻害作用を有するチエノピラゾール誘導体
|
|
US7276631B2
(en)
|
2004-07-20 |
2007-10-02 |
Bristol-Myers Squibb Company |
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
|
|
JO2629B1
(en)
|
2004-08-19 |
2012-06-24 |
افينتيس فارما سوتيكالز انك |
Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
|
|
CA2594665A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Thienopyrroles useful in the treatment of inflammation
|
|
CN100391945C
(zh)
|
2005-05-31 |
2008-06-04 |
浙江大学 |
一种s-(-)-吲哚啉-2-羧酸的合成方法
|
|
US20090306169A1
(en)
|
2005-10-06 |
2009-12-10 |
Brandish Philip E |
Use of Fused Pyrrole Carboxylic Acids for the Treatment of Neurodegenerative and Psychiatric Diseases and D-Amino Acid Oxidase Inhibitors
|
|
UA95788C2
(en)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Fused pyrrole derivatives
|
|
BRPI0706365A2
(pt)
|
2006-01-06 |
2011-03-22 |
Sepracor Inc |
Cicloalquilaminas como inibidores da recaptação de monoamina
|
|
NZ569608A
(en)
|
2006-01-06 |
2011-09-30 |
Sepracor Inc |
Tetralone-based monoamine reuptake inhibitors
|
|
DK2816024T3
(en)
|
2006-03-31 |
2017-10-30 |
Sunovion Pharmaceuticals Inc |
CHIRALE AMINER
|
|
US7579370B2
(en)
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
|
EP2057162A2
(en)
|
2006-06-30 |
2009-05-13 |
Sepracor Inc. |
Fused heterocyclic inhibitors of d-amino acid oxidase
|
|
US20080058395A1
(en)
|
2006-06-30 |
2008-03-06 |
Sepracor Inc. |
Fused heterocyclic inhibitors of D-amino acid oxidase
|
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
|
CN1962656A
(zh)
|
2006-11-29 |
2007-05-16 |
沈阳药科大学 |
吲哚美辛5－氟尿嘧啶甲酯药用化合物及其制剂和制备方法
|
|
US20090099248A1
(en)
|
2007-01-18 |
2009-04-16 |
Sepracor Inc. |
Inhibitors of d-amino acid oxidase
|
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
|
AU2008259841B2
(en)
|
2007-05-31 |
2015-02-05 |
Sunovion Pharmaceuticals Inc. |
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
|
|
WO2010017418A1
(en)
|
2008-08-07 |
2010-02-11 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|